EVQLV
Richard Fox is the Chief Scientific Officer at EVQLV. Previously, Richard was a Director of Preclinical Development at Pure Biologics. Richard holds a Ph.D. in Cardiovascular Pathology from University of Washington.
This person is not in any offices
EVQLV
EVQLV develops artificial intelligence, engineered with life science data, to accelerate how biologic therapies reach patients. They work with partners at the discovery stage to accelerate the speed of antibody discovery.